Related Experiment Video
Updated: Apr 8, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
New insights into malignant cell survival mechanisms in medulloblastoma
Frank Eckerdt1, Stewart Goldman2, Leonidas C Platanias3
1Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, 60611.
Abstract:
mRNA translation and protein synthesis is an important determinant for cell metabolism and cell homeostasis. Perturbations in cellular homeostasis often result in activation of negative feedback loops as compensatory mechanisms. Although, these mechanisms are important for mammalian cells to adjust to environmental changes, they also pose a major challenge for targeted cancer therapy as they provide escape mechanisms for cancer cells. The mammalian target of rapamycin (mTOR) is a crucial regulator of mRNA translation, protein synthesis and metabolism and represents an attractive target for anticancer therapy. We have recently reported that selective inhibition of mTORC1 by rapamycin or its analogs in medulloblastoma cells results in phosphorylation of eukaryotic translation initiation factor 4E (eIF4E) on serine-209, an event known to be associated with induction of protein translation and cell transformation. We have also previously established that this event is mediated by mitogen-activated protein (MAP) kinase-interacting kinase 2 (Mnk2) independently of MAPKs, the conventional activators of Mnks. Here we discuss the implications for our current understanding of negative feedback regulation by mTOR and Mnk in cancer.
Insights
Targeting mTOR in cancer therapy can trigger compensatory feedback loops. Inhibition of mTORC1 by rapamycin activates Mnk2, promoting protein translation and cell transformation, posing a challenge for cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Homeostasis
Background:
- mRNA translation and protein synthesis are critical for cell metabolism and homeostasis.
- Cellular homeostasis perturbations activate negative feedback loops, which can be exploited by cancer cells as escape mechanisms.
- The mammalian target of rapamycin (mTOR) pathway is a key regulator of translation and protein synthesis, making it a target for cancer therapy.
Purpose of the Study:
- To discuss the implications of mTOR inhibition on negative feedback regulation in cancer.
- To explore the role of mitogen-activated protein (MAP) kinase-interacting kinase 2 (Mnk2) in mediating feedback loops.
- To understand how these mechanisms challenge targeted cancer therapy.
Main Methods:
- Selective inhibition of mTORC1 using rapamycin or its analogs in medulloblastoma cells.
- Analysis of eukaryotic translation initiation factor 4E (eIF4E) phosphorylation at serine-209.
- Investigation of Mnk2's role in mediating eIF4E phosphorylation independently of MAPKs.
Main Results:
- Selective mTORC1 inhibition leads to phosphorylation of eIF4E on serine-209.
- This phosphorylation event is associated with induced protein translation and cell transformation.
- Mnk2 mediates this effect independently of conventional MAPK activators.
Conclusions:
- mTOR inhibition can activate compensatory feedback mechanisms involving Mnk2.
- These feedback loops promote protein translation and cell transformation, potentially conferring resistance to cancer therapy.
- Understanding these pathways is crucial for developing more effective cancer treatments targeting mTOR.
More Related Videos
05:10Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
Related Concept Videos
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Treatment Resistant Cancers
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...